VERIFY – Study rationale

VERIFY has the potential to improve the health status and future prospects of millions of people living, or yet to be diagnosed with type 2 diabetes. Find out more about this 5-year on-going Phase 4 trial investigating whether early treatment with a combination of vildagliptin and metformin in people newly diagnosed with type 2 diabetes can induce a durable glycaemic control with favourable outcomes.
Login/ Register Maximise Minimise